title: Does the determination of the Bb vitamin D receptor genotype identify psoriasis vulgaris patients responsive to topical tacalcitol?
authors.forename: Barbara
authors.initials: B
authors.lastname: Giomi
authors.forename: Marco
authors.initials: M
authors.lastname: Ruggiero
authors.forename: Paolo
authors.initials: P
authors.lastname: Fabbri
authors.forename: Massimo
authors.initials: M
authors.lastname: Gulisano
authors.forename: Benedetta
authors.initials: B
authors.lastname: Peruzzi
authors.forename: Marzia
authors.initials: M
authors.lastname: Caproni
authors.forename: Stefania
authors.initials: S
authors.lastname: Pacini
mesh_terms: D000287:Administration, Topical; D000483:Alleles; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D004100:Dihydroxycholecalciferols / Q000008:administration & dosage* / Q000494:pharmacology; D005787:Gene Frequency; D005838:Genotype; D006720:Homozygote; D006801:Humans; D011110:Polymorphism, Genetic; D011565:Psoriasis / Q000188:drug therapy* / Q000235:genetics*; D018167:Receptors, Calcitriol / Q000235:genetics*; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents; D004100:Dihydroxycholecalciferols; D018167:Receptors, Calcitriol; C023850:1 alpha,24-dihydroxyvitamin D3